| Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report M Brunet, T Van Gelder, A Åsberg, V Haufroid, DA Hesselink, L Langman, ... Therapeutic drug monitoring 41 (3), 261-307, 2019 | 615 | 2019 |
| Pitfalls associated with the use of liquid chromatography–tandem mass spectrometry in the clinical laboratory M Vogeser, C Seger Clinical chemistry 56 (8), 1234-1244, 2010 | 341 | 2010 |
| A decade of HPLC–MS/MS in the routine clinical laboratory—Goals for further developments M Vogeser, C Seger Clinical biochemistry 41 (9), 649-662, 2008 | 320 | 2008 |
| After another decade: LC–MS/MS became routine in clinical diagnostics C Seger, L Salzmann Clinical biochemistry 82, 2-11, 2020 | 246 | 2020 |
| Antifungal Stilbenoids from Stemona collinsae T Pacher, C Seger, D Engelmeier, S Vajrodaya, O Hofer, H Greger Journal of Natural Products 65 (6), 820-827, 2002 | 199 | 2002 |
| Feeding Deterrence and Contact Toxicity of Stemona AlkaloidsA Source of Potent Natural Insecticides B Brem, C Seger, T Pacher, O Hofer, S Vajrodaya, H Greger Journal of Agricultural and Food Chemistry 50 (22), 6383-6388, 2002 | 182 | 2002 |
| Therapeutic drug monitoring of everolimus: a consensus report M Shipkova, DA Hesselink, DW Holt, EM Billaud, T Van Gelder, ... Therapeutic drug monitoring 38 (2), 143-169, 2016 | 159 | 2016 |
| Personalized therapy for mycophenolate: consensus report by the international association of therapeutic drug monitoring and clinical toxicology S Bergan, M Brunet, DA Hesselink, KL Johnson-Davis, PK Kunicki, ... Therapeutic drug monitoring 43 (2), 150-200, 2021 | 157 | 2021 |
| The assessment of plant metabolite profiles by NMR-based methodologies E Holmes, H Tang, Y Wang, C Seger Planta Medica 72 (09), 771-785, 2006 | 151 | 2006 |
| A rapid HPLC-MS/MS method for the simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples C Seger, K Tentschert, W Stöggl, A Griesmacher, SL Ramsay Nature Protocols 4 (4), 526-534, 2009 | 145 | 2009 |
| Assuring the proper analytical performance of measurement procedures for immunosuppressive drug concentrations in clinical practice: recommendations of the International … C Seger, M Shipkova, U Christians, EM Billaud, P Wang, DW Holt, ... Therapeutic drug monitoring 38 (2), 170-189, 2016 | 135 | 2016 |
| LC-DAD-MS/SPE-NMR Hyphenation. A Tool for the Analysis of Pharmaceutically Used Plant Extracts: Identification of Isobaric Iridoid Glycoside Regioisomers from Harpagophytum p … C Seger, M Godejohann, LH Tseng, M Spraul, A Girtler, S Sturm, ... Analytical Chemistry 77 (3), 878-885, 2005 | 135 | 2005 |
| Analytical aspects of plant metabolite profiling platforms: current standings and future aims C Seger, S Sturm Journal of proteome research 6 (2), 480-497, 2007 | 131 | 2007 |
| Mass spectrometry and NMR spectroscopy: modern high-end detectors for high resolution separation techniques–state of the art in natural product HPLC-MS, HPLC-NMR, and CE-MS … C Seger, S Sturm, H Stuppner Natural product reports 30 (7), 970-987, 2013 | 121 | 2013 |
| The value of universally available raw NMR data for transparency, reproducibility, and integrity in natural product research JB McAlpine, SN Chen, A Kutateladze, JB MacMillan, G Appendino, ... Natural product reports 36 (1), 35-107, 2019 | 114 | 2019 |
| Antioxidant dehydrotocopherols as a new chemical character of Stemona species B Brem, C Seger, T Pacher, M Hartl, F Hadacek, O Hofer, S Vajrodaya, ... Phytochemistry 65 (19), 2719-2729, 2004 | 94 | 2004 |
| Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system B Seeber, SC Ziehr, A Gschlieβer, C Moser, V Mattle, C Seger, ... Contraception 86 (4), 345-349, 2012 | 89 | 2012 |
| 1H and 13C NMR signal assignment of cucurbitacin derivatives from Citrullus colocynthis (L.) Schrader and Ecballium elaterium L. (Cucurbitaceae) C Seger, S Sturm, ME Mair, EP Ellmerer, H Stuppner Magnetic Resonance in Chemistry 43 (6), 489-491, 2005 | 83 | 2005 |
| Usage and limitations of liquid chromatography-tandem mass spectrometry (LC-MS/MS) in clinical routine laboratories. C Seger Wiener Medizinische Wochenschrift (1946) 162 (21-22), 499-504, 2012 | 76 | 2012 |
| FGF 23 is associated with disease severity and prognosis in chronic heart failure G Poelzl, C Trenkler, J Kliebhan, P Wuertinger, C Seger, S Kaser, ... European journal of clinical investigation 44 (12), 1150-1158, 2014 | 74 | 2014 |
Michael VogeserUniversity of MunichZweryfikowany adres z med.uni-muenchen.de
